Trademarkia Logo

Canada

C$
Trademark Search in Canada
VAXO-Q-RE

View On IC.GC.CA

VAXO-Q-RE
REGISTERED

on 2 Apr 2025

Last Applicant/ Owned by

R.G.C.C. Holdings AG

Baarerstrasse 95CH-6300 Zug

CH

Serial Number

2197715 filed on 4th Apr 2022

Registration Number

TMA1303852 registered on 2th Apr 2025

Registration expiry Date

4th Apr 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

VAXO-Q-RE

Trademark usage description

préparations et substances pharmaceutiques pour le traitement du cancer. recherche scientifique et analyse dans le domaine de l'immunothérapie du can Read More

Classification Information

Class [005]
Préparations et substances pharmaceutiques pour le traitement du cancer.

Classification kind code

11

Class [042]
Recherche scientifique et analyse dans le domaine de l'immunothérapie du cancer, de la thérapie cellulaire adoptive et de la thérapie génique, et culture de cellules primaires et de tissus humains; recherche dans le domaine de la thérapie génique; services de laboratoire scientifique concernant l'isolement, la culture, l'activation et l'expansion de cellules primaires et de tissus humains.

Classification kind code

11

Class [044]
Services de diagnostic médical.

Classification kind code

11

Mark Details

Serial Number

2197715

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 22nd Jan 2024		Agent Changed
Submitted for opposition 22
on 18th Oct 2023		Search Recorded
Submitted for opposition 20
on 18th Oct 2023		Examiner's First Report
Submitted for opposition 223
on 18th Oct 2023		Total Provisional Refusal
Submitted for opposition 256
on 15th May 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 14th Jul 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 13th Jul 2022		Created
Submitted for opposition 31
on 13th Jul 2022		Formalized
Submitted for opposition 228
on 4th Apr 2022		International Registration
Submitted for opposition 30
on 4th Apr 2022		Filed